Study on the efficacy of early treatment with pirfenidone on the lung function of patients with idiopathic pulmonary fibrosis

doi:10.12998/wjcc.v12.i22.4913

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 22

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (563)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-6) series, Tables (1-6) series.

Item

Count

PDF

HTML

368

Figures (1-6)

Tables (1-6)

Sum=496

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

Sum=42

Aug 6, 2024 (publication date) through Aug 24, 2024

Times Cited of This Article

Times Cited (1)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Clin Cases. Aug 6, 2024; 12(22): 4913-4923
Published online Aug 6, 2024. doi: 10.12998/wjcc.v12.i22.4913

Full Size Figure Download Figure

Figure 5 Comparison of inflammatory factor indicators between the two groups of patients. A: C-reactive protein (CRP); B: Interleukin 2 (IL-2); C: IL-8.

Citation: Lei Y, Sheng JH, Jin XR, Liu XB, Zheng XY, Xu XH. Study on the efficacy of early treatment with pirfenidone on the lung function of patients with idiopathic pulmonary fibrosis. World J Clin Cases 2024; 12(22): 4913-4923
URL: https://www.wjgnet.com/2307-8960/full/v12/i22/4913.htm
DOI: https://dx.doi.org/10.12998/wjcc.v12.i22.4913